Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardio-endocrine diseases. The company’s lead program, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly.
| Website | http://www.mareatx.com |
| Employees | 43 (33 on RocketReach) |
| Phone | +1 415-766-3610 |
| Industry | Biotechnology Research |
| Competitors | bluebird bio, Editas Medicine, Intellia Therapeutics, Inc., CRISPR Therapeutics, REGENXBIO Inc., Abeona Therapeutics, Rocket Pharmaceuticals, Sangamo Therapeutics, Inc., Genprex, Inc., Precision BioSciences, Inc. +38 more (view full list) |
Looking for a particular Marea Therapeutics employee's phone or email?
Marea Therapeutics Questions
Ian Clements is the CFO of Marea Therapeutics.
33 people are employed at Marea Therapeutics.
Marea Therapeutics is based in San Francisco, California.
Top Marea Therapeutics Employees
-
Ian Clements
Chief Financial Officer at Marea Therapeutics
California, United States23 -
Ethan Weiss
Chief Scientific Officer at Marea Therapeutics
San Francisco, CA, US45+ -
May Liu
Vice President, Corporate Controller at Marea Therapeutics
San Francisco, CA, US5+5+ -
Shishir Gadam
Chief Technical Officer at Marea Therapeutics
San Mateo, CA, US24 -
Rebecca Juliano
Chief Development Officer at Marea Therapeutics
Madison, NJ, US23 -
5+5+
-
Maria Costa
Vice President, Head of Biology at Marea Therapeutics
South San Francisco, CA, US45+ -
Karen Dittrich
VP Program and Portfolio Management at Marea Therapeutics
South San Francisco, CA, US35 -
Max Zeiberg
Senior Vice President, Corporate Development at Marea Therapeutics
South San Francisco, CA, US24 -
Yining Ye
Vice President at Marea Therapeutics
California, United States25
